If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Tirzepatide
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
There is no information on the use of tirzepatide in people with T1DM because patients with T1DM were excluded from tirzepatide clinical trials. At this time, we do not have plans to conduct tirzepatide clinical trials in people with T1DM.
T1DM = type 1 diabetes mellitus
Date of Last Review: March 02, 2021
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 7pm EST